Functional convergence amid taxonomic variability in gut microbiome–immune checkpoint inhibitor research: a bibliometric and mechanistic synthesis

• by Yousef N. Alanazi

• July 14, 2026

First-line penpulimab combined with anlotinib achieves complete response in an elderly patient with occult lung squamous cell carcinoma: a case report

• by Xiaoling Zhu, Yinan Yu, Wei Si, Jun Xu

• July 14, 2026

Inside VIVEbiotech’s Work with Zelluna on TCR-NK Cell Therapy

VIVEbiotech CEO Jon Alberdi lifts the lid on an eight-year collaboration focused on GMP lentiviral vectors for off-the-shelf solid tumor therapies

• July 14, 2026

• 4 min

Effects of donor killer-cell immunoglobulin-like receptor genotypes on clinical outcome after allogeneic hematopoietic stem cell transplantation—a systematic review and meta-analysis

• by Yarui Huang, Qingrong Li, Xin Xu, Ju Li, Yan Zhu, Chengxin Luo, Jiegang Xu, Jiaming Liu, Jianmin Zhang, Ping Wang, Ya Tan, Yaqun Ding, Shuangnian Xu, Run Chen, Ling Wei

• July 14, 2026